<DOC>
	<DOCNO>NCT00251368</DOCNO>
	<brief_summary>The purpose study evaluate side effect 9-Aminocamptothecin ( 9-AC ) determine best dose use treat leukemia .</brief_summary>
	<brief_title>Multicenter Study 9-Aminocamptothecin ( 9-AC ) Patients With Refractory Leukemia</brief_title>
	<detailed_description>- The treatment patient receive involve continuous infusion 9-AC intravenously 72 hour period . Since unsure safest effective dose , successive group 4-7 patient receive large dos drug large dose give safely establish . - Prior start therapy bone marrow aspirate biopsy take diagnostic research purpose . A bone marrow exam repeat 48 hour order determine effect 9-AC leukemic cell bone marrow . A bone marrow scan also perform 14 day start therapy ass response . - Frequent blood test do throughout treatment , include blood sample determine level 9-AC blood . - Treatment could stop prematurely follow occur : 1 ) drug cause severe side effect , 2 ) drug control leukemia , 3 ) doctor patient feel longer patient best interest receive therapy . - Approximately 7 day conclusion 9-AC infusion , likely patient 's blood count low require support antibiotic , red cell transfusion platelet transfusion .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>9-aminocamptothecin</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<criteria>18 year age old AML ALL first subsequent relapse , secondary AML , CML blastic phase Central venous access ECOG performance status less equal 2 Bilirubin &lt; 1.3 SGOT &lt; 2 x ULN Alkaline phosphatase &lt; 2 x ULN Creatinine &lt; 1.5 Undergone bone marrow transplantation Uncontrolled infection Other active malignancy HIV positivity Serious medical psychiatric illness Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>leukemia</keyword>
	<keyword>9-Aminocamptothecin</keyword>
	<keyword>AML</keyword>
	<keyword>ALL</keyword>
	<keyword>refractory leukemia</keyword>
	<keyword>relapse leukemia</keyword>
</DOC>